Trial site
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie
- 11running trials
- 12closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Haemophilia3 trials
- Myeloproliferative neoplasms3 trials
- Childhood cancers2 trials
- Mild cognitive impairment2 trials
- Ulcerative colitis2 trials
- Acute lymphoblastic leukaemia1 trial
- Atrial fibrillation1 trial
- Chronic myeloid leukaemia1 trial
- Follicular lymphoma1 trial
- High blood pressure1 trial
- Hodgkin lymphoma1 trial
- and 4 more
- Phase
- Phase 312 trials
- Phase 26 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed12 trials
- Active, not recruiting7 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S4 trials
- Incyte Corporation2 trials
- Janssen Research & Development, LLC2 trials
- Spruce Biosciences2 trials
- Alexion Pharmaceuticals, Inc.1 trial
- and 12 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Hodgkin lymphoma1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Terminated
A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH
Terminated
A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026